company background image
BIOC logo

GlaxoSmithKlineE CASE:BIOC Stock Report

Last Price

ج.م38.91

Market Cap

ج.م3.2b

7D

-4.8%

1Y

9.1%

Updated

23 Dec, 2024

Data

Company Financials

GlaxoSmithKline S.A.E

CASE:BIOC Stock Report

Market Cap: ج.م3.2b

BIOC Stock Overview

Engages in the production of pharmaceutical chemicals in Egypt. More details

BIOC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends1/6

Rewards

Became profitable this year

Risk Analysis

Volatile share price over the past 3 months compared to the EG market

Large one-off items impacting financial results

Does not have a meaningful market cap (EGP3B)


My Notes

Capture your thoughts, links and company narrative

GlaxoSmithKline S.A.E Competitors

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E

CASE:RMDA

ج.م5.0b

Kahira Pharmaceuticals & Chemical Industries

CASE:CPCI

ج.م1.7b

Alexandria For Pharmaceuticals & Chemical Industries

CASE:AXPH

ج.م1.6b

Egyptian International Pharmaceutical Industries

CASE:PHAR

ج.م6.7b

Price History & Performance

Summary of share price highs, lows and changes for GlaxoSmithKlineE
Historical stock prices
Current Share Priceج.م38.91
52 Week Highج.م47.50
52 Week Lowج.م24.70
Beta1.04
1 Month Change-4.12%
3 Month Change9.85%
1 Year Change9.05%
3 Year Change32.35%
5 Year Change96.91%
Change since IPO317.49%

Recent News & Updates

Recent updates

Shareholder Returns

BIOCEG PharmaceuticalsEG Market
7D-4.8%-2.4%-2.0%
1Y9.1%32.2%28.2%

Return vs Industry: BIOC underperformed the EG Pharmaceuticals industry which returned 32.2% over the past year.

Return vs Market: BIOC underperformed the EG Market which returned 28.2% over the past year.

Price Volatility

Is BIOC's price volatile compared to industry and market?
BIOC volatility
BIOC Average Weekly Movement8.7%
Pharmaceuticals Industry Average Movement7.3%
Market Average Movement5.6%
10% most volatile stocks in EG Market8.7%
10% least volatile stocks in EG Market3.3%

Stable Share Price: BIOC's share price has been volatile over the past 3 months compared to the EG market.

Volatility Over Time: BIOC's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of EG stocks.

About the Company

FoundedEmployeesCEOWebsite
1981n/aHassan Fahmiwww.gsk.com/en-gb/contact-us/worldwide/egypt

GlaxoSmithKline S.A.E. engages in the production of pharmaceutical chemicals in Egypt. It is also involved in the manufacture of medical preparations and cosmetics. The company was founded in 1981 and is headquartered in New Cairo City, Egypt.

GlaxoSmithKline S.A.E Fundamentals Summary

How do GlaxoSmithKlineE's earnings and revenue compare to its market cap?
BIOC fundamental statistics
Market capج.م3.25b
Earnings (TTM)ج.م119.55m
Revenue (TTM)ج.م2.81b

27.2x

P/E Ratio

1.2x

P/S Ratio

Is BIOC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOC income statement (TTM)
Revenueج.م2.81b
Cost of Revenueج.م1.63b
Gross Profitج.م1.17b
Other Expensesج.م1.05b
Earningsج.م119.55m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.43
Gross Margin41.79%
Net Profit Margin4.26%
Debt/Equity Ratio26.9%

How did BIOC perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

52%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 22:55
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GlaxoSmithKline S.A.E is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution